| Videos | Channels | Search |
Berger: How I’m trading the US stock sell-off
It’s been a rough start to the year for many assets including equities, which have seen a dramatic sell-off. But could that offer traders buying opportunities? Serge Berger thinks so and here’s why.
Biotechnology stocks are among the assets, which have come under pressure. According to Berger, the Nasdag biotechnology ETF IBB is down 25% since late December. But the ETF looks oversold and after staging bullish reversal on Thursday, Berger thinks it is time to buy. He is looking to buy at USD 290 with a stop at USD 278 and a target for the trade at USD 278.
01:29 minutes
Tags: asset, assets, bank, banking, berger, biotech, biotechnology, buy, buying, capital, equities, equity, etf, group, ibb, index, markets, nasdaq, off, opportunities, opportunity, saxo, saxobank.com, saxotrader, saxotradergo, saxotv, sell, selling, selloff, serge, share, shares, stock, stocks, stop, tale, target, targets, trade, trader, traders, trades, trading, tradingfloor, tradingfloor.com, tradingfloorcom, tv, united states, us, view
Switch to